Evidence analysisNovember 18, 2026Evidence

Detection of Mycobacterium africanum Lineage 6 in White-Nosed Coatis, Costa Rica

FreedomWitness Evidence Engine: This is an AI-assisted original analysis built from the linked source and available public source context. It separates evidence from interpretation and may challenge conventional framing only where the evidence supports it. It is not a copied article.

Detection of Mycobacterium africanum Lineage 6 in White-Nosed Coatis, Costa Rica: An Evidence Dossier

What is Established

Mycobacterium africanum (M. africanum), a member of the Mycobacterium tuberculosis complex (MTBC), is known primarily as a cause of tuberculosis (TB) in humans in West Africa, where it accounts for approximately half of TB cases in some regions. Traditionally considered adapted to humans, M. africanum has occasionally been found infecting domestic and wild animals, suggesting it may have a broader host range. However, until recently, confirmed infections in free-ranging wildlife in the Americas were not documented.

White-nosed coatis (Nasua narica), common free-ranging mammals in Central America, had not previously been identified as hosts for M. africanum. Samples from wildlife in Costa Rica detected acid-fast bacilli and granulomatous disease consistent with mycobacterial infection.

What the Source Claims

A 2026 publication in the Emerging Infectious Diseases Journal by Aguilar-Vargas et al. presents evidence of Mycobacterium africanum lineage 6 infection in white-nosed coatis in Costa Rica, marking the first such report in free-ranging wildlife in the Americas. This evidence emerged from investigation of eight male, free-ranging coatis presenting with nodular or ulcerative skin lesions and pulmonary disease between 2024 and 2026.

The study used necropsies, histopathology, culture, molecular diagnostics (PCR, next-generation sequencing), and genomic assays to confirm M. africanum lineage 6 as the causative agent of a disseminated granulomatous disease affecting multiple organs in the coatis. The isolates were confirmed through targeted next-generation sequencing (tNGS) and other genotyping methods, which placed the strains firmly within lineage 6 of M. africanum.

The infected coatis exhibited clinical signs ranging from localized skin masses to extensive ulcerative lesions, severe pneumonia, and overall poor health, with all affected individuals eventually dying despite empirical antimicrobial treatment. The study highlights the potential presence of a traditionally human-associated pathogen in new wildlife species and geographic regions, emphasizing the importance of wildlife surveillance in detecting emergent zoonotic and reverse-zoonotic disease threats.

What May Be Missing from the Usual Framing

  • Source of Infection and Transmission Pathways: The study does not definitively establish how M. africanum lineage 6 was introduced to free-ranging coatis in Costa Rica. There is no direct evidence of transmission pathways either between humans and coatis or within wildlife populations.
  • Extent of Zoonotic or Reverse-Zoonotic Risk: While M. africanum is known in humans in West Africa and rarely in the Americas, the study does not provide evidence on whether infected coatis pose a risk of transmission to humans or other animals, nor the potential public health impact.
  • Environmental or Ecological Context: The ecological drivers contributing to infection emergence in an animal species outside the known geographic range remain unexplained. Factors such as habitat interactions, coati behavior, human encroachment, or environmental reservoirs are not addressed.
  • Antimicrobial Resistance and Treatment Response: Although some coatis were treated empirically with antibiotics, the study does not offer detailed data on antimicrobial susceptibility or resistance profiles of the isolates to inform treatment or containment strategies.

Competing Evidence or Uncertainty

The detection of M. africanum lineage 6 in Costa Rican wildlife challenges prior assumptions about the pathogen’s geographic confinement to West Africa and its host range. However, uncertainties remain due to limited sample size (eight coatis) and lack of broader surveillance data. Other explanations such as laboratory contamination are addressed by the authors through inclusion of negative controls and independent confirmations but cannot be entirely excluded without replication.

The natural history of M. africanum in wildlife is poorly understood. Previous sporadic reports in domestic and wild animals have suggested a wider host range, but these remain rare. The phylogenetic closeness of lineage 6 to animal-adapted strains provides some biological rationale for wildlife infection, though epidemiological dynamics in the Americas are not well-characterized.

Why It Matters

This finding could have important implications for One Health frameworks integrating human, animal, and environmental health. The presence of M. africanum in wildlife in a new continent may indicate unnoticed pathogen movement or underappreciated reservoirs that complicate TB control strategies. It highlights the role of wildlife surveillance in detecting emerging infectious diseases before they pose broader risks to public health or biodiversity.

Understanding pathogen spillover potential and host adaptation in wildlife can inform risk assessments for zoonotic transmission and guide interventions, including habitat management, wildlife health monitoring, and human-wildlife interaction policies. The case also exemplifies challenges in managing bacterial pathogens with complex ecology and evolution.

What to Verify Next

  • Broader Surveillance: Enhanced molecular surveillance in wildlife, livestock, and human populations in Costa Rica and neighboring regions to determine the prevalence and geographic distribution of M. africanum lineage 6.
  • Transmission Studies: Investigations into possible transmission routes, including environmental sources, human-to-animal or animal-to-human contacts, and intra-species spread among wildlife.
  • Genomic Comparisons: Comparative genomics to characterize genetic diversity of isolates from coatis versus those from known human or animal hosts globally, to better understand pathogen evolution.
  • Ecological and Epidemiological Context: Studies on habitat use, population dynamics, and ecological factors influencing infection risks in coatis to identify drivers of emergence and potential intervention points.
  • Public Health Risk Assessment: Assessment of potential zoonotic risk, including screening of at-risk human populations and evaluation of clinical significance of coati-associated strains.

Readers interested in detailed methodologies, data, and interpretations should consult the original article published by Aguilar-Vargas et al. in the Emerging Infectious Diseases Journal, December 2026 issue.

Source & verification

Primary source: Emerging Infectious Diseases Journal · November 10, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.

Continue reading

EudraGMDP database

What is established The EudraGMDP database is an established European Union (EU) information system managed by the European Medicines Agency (EMA). It serves as…